Accueil > La recherche > Les Equipes > Glyco et Nanovecteurs pour le ciblage Thérapeutique

Publications de l’équipe

par Marcel Garcia - publié le , mis à jour le

Publis 2020

1. Reverse poly(ε-caprolactone)-g-dextran graft copolymers. Nano-carriers for intracellular uptake of anticancer drugs. Delorme V, Lichon L, Mahindad H, Hunger S, Laroui N, Daurat M, Godefroy A, Coudane J, Gary-Bobo M, Van Den Berghe H.
Carbohydr Polym. 2020 Mar 15 ;232:115764. doi : 10.1016/j.carbpol.2019.115764

2. Biological Assessment of Laser-Synthesized Silicon Nanoparticles Effect in Two-Photon Photodynamic Therapy on Breast Cancer MCF-7 Cells. Al-Kattan A, M A Ali L, Daurat M, Mattana E, Gary-Bobo M.
Nanomaterials (Basel). 2020 Jul 26 ;10(8):E1462. doi : 10.3390/nano10081462.

3. Pyclen-Based Ln(III) Complexes as Highly Luminescent Bioprobes for In Vitro and In Vivo One- and Two-Photon Bioimaging Applications. Hamon N, Roux A, Beyler M, Mulatier JC, Andraud C, Nguyen C, Maynadier M, Bettache N, Duperray A, Grichine A, Brasselet S, Gary-Bobo M, Maury O, Tripier R.
J Am Chem Soc. 2020 Jun 3 ;142(22):10184-10197. doi : 10.1021/jacs.0c03496.

4. Sequential delivery of synergistic drugs by silica nanocarriers for enhanced tumour treatment. Birault A, Giret S, Théron C, Gallud A, Da Silva A, Durand D, Nguyen C, Bettache N, Gary-Bobo M, Bartlett JR, Wong Chi Man M, Carcel C.
J Mater Chem B. 2020 Feb 19 ;8(7):1472-1480. doi:10.1039/c9tb02225b.

5. The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics. Daurat M , Nguyen C , Dominguez Gil S , Sol V , Chaleix V , Charnay C , Raehm L , El Cheikh K , Morère A , Bernasconi M , Timpanaro A , Garcia M , Cunin F , Roessler J , Durand JO , Gary-Bobo M.
Biomater Sci. 2020 Jul 7 ;8(13):3678-3684. doi : 10.1039/d0bm00586j. Epub 2020 May 29.

6. Fashioning Prussian Blue Nanoparticles by Adsorption of Luminophores : Synthesis, Properties, and in Vitro Imaging. Mamontova E, Daurat M, Long J, Godefroy A, Salles F, Guari Y, Gary-Bobo M, Larionova J.
Inorg Chem. 2020 Apr 6 ;59(7):4567-4575. doi : 10.1021/acs.inorgchem.9b03699.

7. Polythiophenes with Cationic Phosphonium Groups as Vectors for Imaging, siRNA Delivery, and Photodynamic Therapy. Lichon L, Kotras C, Myrzakhmetov B, Arnoux P, Daurat M, Nguyen C, Durand D, Bouchmella K, Ali LMA, Durand JO, Richeter S, Frochot C, Gary-Bobo M, Surin M, Clément S.
Nanomaterials (Basel). 2020 Jul 22 ;10(8):E1432. doi : 10.3390/nano10081432.

8. Degradable double hydrophilic block copolymers and tripartite polyionic complex micelles thereof for small interfering ribonucleic acids (siRNA) delivery. El Jundi A, Morille M, Bettache N, Bethry A, Berthelot J, Salvador J, Hunger S, Bakkour Y, Belamie E, Nottelet B.
J Colloid Interface Sci. 2020 Jul 15 ;580:449-459. doi : 10.1016/j.jcis.2020.07.057.

9. Vegetable Oil-based Hybrid Microparticles as a Green and Biocompatible System for Subcutaneous Drug Delivery. Doufène K, Basile I, Lebrun A, Pirot N, Escande A, Chopineau J, Devoisselle JM, Bettache N, Aubert-Pouëssel A.
Int J Pharm. 2020 Nov 11:120070. doi : 10.1016/j.ijpharm.2020.120070.

10. Cytotoxic activities of Psidium guajava and Mangifera indica plant extracts on human healthy skin fibroblasts and human hepatocellular carcinoma. G.A. Kemegne, N. Bettache, M.A. Nyegue, F.-X. Etoa, C. Menut,
Biological Sciences and Pharmaceutical Research, 2020, 8(4), 58-64.

11. Androgenic hormones and the excess male mortality observed in COVID-19 patients : new convergent data. Lamy PJ, Rébillard X, Vacherot F, de la Taille A.
World J Urol. 2020 Jun 2:1-3. doi : 10.1007/s00345-020-03284-y.

12. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis : an observational case-control study. Houédé N, Rébillard X, Bouvet S, Kabani S, Fabbro-Peray P, Trétarre B, Ménégaux F.
BMC Cancer. 2020 Aug 12 ;20(1):757. doi : 10.1186/s12885-020-07244-y.

13. Circadian genes polymorphisms, night work and prostate cancer risk : Findings from the EPICAP study. Wendeu-Foyet MG, Cénée S, Koudou Y, Trétarre B, Rébillard X, Cancel-Tassin G, Cussenot O, Boland A, Olaso R, Deleuze JF, Blanché H, Lamy PJ, Mulot C, Laurent-Puig P, Truong T, Menegaux F.
Int J Cancer. 2020 Jun 7. doi : 10.1002/ijc.33139.

14. Epidemiology of metastatic castration-resistant prostate cancer : A first estimate of incidence and prevalence using the French nationwide healthcare database. Thurin NH, Rouyer M, Gross-Goupil M, Rebillard X, Soulié M, Haaser T, Roumiguié M, Le Moulec S, Capone C, Pierrès M, Lamarque S, Jové J, Bignon E, Droz-Perroteau C, Moore N, Blin P.
Cancer Epidemiol. 2020 Oct 14 ;69:101833. doi : 10.1016/j.canep.2020.101833.

15. Synergic effect of doxorubicin release and two-photon irradiation of Mn 2+ -doped Prussian blue nanoparticles on cancer therapy.
Lamiaa M. A. Ali, Emna Mathlouthi, Maëlle Cahu, Saad Sene, Morgane Daurat, Jérôme Long, ORCID, Yannick Guari, Fabrice Salles, Joël Chopineau, Jean-Marie Devoisselle, Joulia Larionova and Magali Gary-Bobo. 2020 RSC Advances. doi : 10.1039/C9RA09133E

Publis 2019

1- Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells. Rahmani S, Budimir J, Sejalon M, Daurat M, Aggad D, Vivès E, Raehm L, Garcia M, Lichon L, Gary-Bobo M, Durand JO, and Charnay C.. Molecules, 2019, 24, 332, doi:10.3390/molecules24020332.

2 -New precursors for the preparation of pH-sensitive, targeting, and loaded non-porous bridged silsesquioxane nanoparticles. Theron C, Birault A, Bernhardt M, Ali LMA, Nguyen C, Gary-Bobo M, Bartlett JR, Man MWC, Carcel C. JSGSAT, 2019,89, 45,doi : 10.1007/s10971-018-4676-0.

3- Dendrimeric Nanoparticles for Two-Photon Photodynamic Therapy and Imaging : Synthesis, Photophysical Properties, Innocuousness in Daylight and Cytotoxicity under Two-Photon Irradiation in the NIR. Sourdon A, Gary-Bobo M, Maynadier M, Garcia M, Majoral JP, Caminade AM, Mongin O, Blanchard-Desce M, 2019, 25, 3637, doi : 10.1002/chem.201805617

4- Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor. Bouffard E, Jimenez CM, El Cheikh K, Maynadier M, Basile I, Raehm L, Nguyen C, Gary-Bobo M, Garcia M, Durand JO, Morere A, 2019, 20, 2809, doi : 10.3390/ijms20112809

5- Organosilica Nanoparticles for Gemcitabine Monophosphate Delivery in Cancer Cells. Daurat M, Rahmani S, Bouchal R, Akrout A, Budimir J, Nguyen C, Charnay C, Guari Y, Richeter S, Raehm L, Bettache N, Gary-Bobo M, Durand JO, Hesemann P, 2019, 5,888, doi : 10.1002/cnma.201900202

6- A « Multi-Heavy-Atom » Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties. Galland M, Le Bahers T, Banyasz A, Lascoux N, Duperray A, Grichine A, Tripier R, Guyot Y, Maynadier M, Nguyen C, Gary-Bobo M, Andraud C, Monnereau C, Maury O, 2019, 25, 9026, doi : 10.1002/chem.201901047

7- Mannose 6-phosphonate labelling : A key for processing the therapeutic enzyme in Pompe disease. Godefroy A, Daurat M, Da Silva A, Basile I, El Cheikh K, Caillaud C, Sacconi S, Schoser B, Charbonne HV, Gary-Bobo M, Morere A, Garcia M, Maynadier M, 2019, 23,6499,doi : 10.1111/jcmm.14516

8- Synthesis and Anticancer Activity of Gold Porphyrin Linked to Malonate Diamine Platinum Complexes. Toubia I, Nguyen C, Diring S, Ali LMA, Larue L, Aoun R, Frochot C, Gary-Bobo M, Kobeissi M, Odobel F, 2019, 58, 12395, doi : 10.1021/acs.inorgchem.9b01981

9- Topological Requirements for CI-M6PR-Mediated Cell Uptake. Ali LMA, Simon M, El Cheikh K, Aguesseau-Kondrotas J, Godefroy A, Nguyen C, Garcia M, Morere A, Gary-Bobo M, Maillard L, 2019, 30, 2533, doi : 10.1021/acs.bioconjchem.9b00590

10- Phthalocyanine-based mesoporous organosilica nanoparticles : NIR photodynamic efficiency and siRNA photochemical internalization. Ekineker G, Nguyen C, Bayir S, Dominguez Gil S, Isci U, Daurat M, Godefroy A, Raehm, L, Charnay C, Oliviero E, Ahsen, Vefa, Gary-Bobo M, Durand JO, Dumoulin F, 2019, 55, 11619, doi : 10.1039/c9cc05703j

11- Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes. Laroui N, Coste M, Lichon L, Bessin Y, Gary-Bobo M, Pratviel G, Bonduelle C, Bettache N, Ulrich S, 2019, 569, 118585, doi : 10.1016/j.ijpharm.2019.118585

12- Biocompatible conjugated fluorenylporphyrins for two-photon photodynamic therapy and fluorescence imaging. Shi LM, Nguyen C, Daurat M, Dhieb AC, Smirani W, Blanchard-Desce M, Gary-Bobo M, Mongin O, Paul-Roth C, Paul F, 2019, 55, 12231, doi : 10.1039/c9cc05657b

13- Encapsulation of Upconversion Nanoparticles in Periodic Mesoporous Organosilicas. Rahmani S, Jimenez CM, Aggad D, Gonzalez-Mancebo D, Ocana M, Ali LMA, Nguyen C, Nieto AIB, Francolon N, Oliveiro E, Boyer D, Mahiou R, Raehm L, Gary-Bobo M, Durand JO Charnay C, 2019, 24, 22, doi : 10.3390/molecules24224054

14- The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex. Kassouf T, Larive RM, Morel A, Urbach S, Bettache N, Marcial Medina MC, Mèrezègue F, Freiss G, Peter M, Boissière-Michot F, Solassol J, Montcourrier P, Coopman P.Cancers (Basel). 2019 Dec 7 ;11(12):1974. doi : 10.3390/cancers11121974

15- Inhibitory effects of essential oils from Ocimum basilicum and Ocimum gratissimum on Colletotrichum musae : The causal agent of bananas anthracnose. Madjouko MA, Tchameni SN, Tchinda, ES, Jazet PMD, Kamsu PN, Kamga VAMS, Sameza ML, Tchoumbougnang F, Menut C, 2019, 167, 257, doi : 10.1111/jph.12793

16- Applying the hydrodistillation process to Pentadiplandra brazzeana Baill. root : a chemical assessment. Nyegue MA, Montaut S, De Nicola GR, Rollin P, Menut C, 2019, 33, 1383, doi : 10.1080/14786419.2018.1475380

17- Introducing Students to Mechanochemistry via Environmentally Friendly Organic Synthesis Using a Solvent-Free Mechanochemical Preparation of the Antidiabetic Drug Tolbutamide. Colacino E, Dayaker G, Morere A, Friscic T, 2019, 96, 766, doi : 10.1021/acs.jchemed.8b00459

18- Short version of recommendations for enhanced recovery program (ERP) for cystectomy : Technical measures. Poinas G, Blache JL, Kassab-Chahmi D, Evrard PL, Artus PM, Alfonsi P, Rébillard X, Beaussier M, Cerantola Y, Coloby P, Drapier É, Houédé N, Masson-Lecomt A, Rouprêt M, Le Normand L, Gamé X, Bosset PO, Delaunay L, Fendler JP, Ecoffey C, Cuvelier G, 2019, 29, 63, doi : 10.1016/j.purol.2018.12.002

19- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Carlsson SV, Talala KM, Lilja H, Denis LJ, Recker F, Paez A, Puliti D, Villers A15, Rebillard X, Kilpeläinen TP, Stenman UH, Godtman RA, Stinesen Kollberg K, Moss SM, Kujala P, Taari K, Huber A, van der Kwast T, Heijnsdijk EA, Bangma C, De Koning HJ, Schröder FH, Auvinen A ; ERSPC investigators, 2019, 76, 43, doi : 10.1016/j.eururo.2019.02.009

20- THE RELATION BETWEEN BASELINE PSA, CANCER DETECTION AND PC DEATH, LONG-TERM DATA FROM ERSPC. Roobol MJ, Remmers S, Carlsson S, Auvinen A, Tammela T, Denis L, Nelen V, Villers A, Rebillard X, Kwiatkowski M, Recker F, Zappa M, Puliti D, Paez A, Lujan M, Bangma C, 2019, 201, E1181

21 Circadian genes and risk of prostate cancer : Findings from the EPICAP study. Wendeu-Foyet MG, Koudou Y, Cénée S, Trétarre B, Rébillard X, Cancel-Tassin G, Cussenot O, Boland A, Bacq D, Deleuze JF, Lamy PJ, Mulot C, Laurent-Puig P, Truong T, Menegaux F, 2019, 145, 1745, doi : 10.1002/ijc.32149.

22- Guidelines for reporting secondary findings of genome sequencing in cancer genes : the SFMPP recommendations. Pujol P, Vande Perre P, Faivre L, Sanlaville D, Corsini C, Baertschi B, Anahory M, Vaur D, Olschwang S, Soufir N, Bastide N, Amar S, Vintraud M, Ingster O, Richard S, Le Coz P, Spano JP, Caron O, Hammel P, Luporsi E, Toledano A, Rebillard X, Cambon-Thomsen A, Putois O, Rey JM, Hervé C, Zorn C, Baudry K, Galibert V, Gligorov J, Azria D, Bressac-de Paillerets B, Burnichon N, Spielmann M, Zarca D, Coupier I, Cussenot O, Gimenez-Roqueplo AP, Giraud S, Lapointe AS, Niccoli P, Raingeard I, Le Bidan M, Frebourg T, Rafii A, Geneviève D, 2019, 27, 562

23- BODY MASS INDEX TRAJECTORIES AND PROSTATE CANCER RISK IN THE EPICAP STUDY. Lavalette C, Duverger EC, Cenee S, Rebillard X, Lamy PJ, Tretarre B, Menegaux F, 2019, 73, A33, doi : 10.1136/jech-2019-SSMabstracts.70

24- ABDOMINAL OBESITY AND PROSTATE CANCER RISK : RESULTS FROM THE EPICAP STUDY. Lavalette C, Trétarre B, Rebillard X, Lamy PJ, Cénée S, Menegaux F, 2019, 73, A85, doi : 10.1136/jech-2019-SSMabstracts.182

Publis 2018

1- Hollow Organosilica Nanoparticles for Drug Delivery. Rahmani S., Akroua A., Budimir J., Aggad D., Daurat M., Godefroy A., Nguyen C., Largot H.,Gary-Bobo M., Raehm L., Durand JO., Charnay, C., Hollow Organosilica Nanoparticles for drug delivery. 2018. ChemistrySelect. 3(37):10439-10442. DOI : 10.1002/slct.201802107

2- Biomolecular dynamic covalent polymers for DNA complexation and siRNA delivery. Bouillon, C., Bessin Y., Poncet F., Gary-Bobo M., Dumy P., Barboiu M., Bettache* N., and Ulrich* S. 2018. Journal of Materials Chemistry B. DOI : 10.1039/C8TB01278D.

3- Gemcitabine Delivery and Photodynamic Therapy in cancer cells via Porphyrin-Ethylene-Based Periodic Mesoporous Organosilica Nanoparticles. Aggad D, Mauriello Jimenez C, Dib S, Croissant Jg, Lichon L, Laurencin D, Richeter S, Maynadier M, Alsaiari Sk, Boufatit M, Raehm L, Garcia M, Khashab Nm, Gary-Bobo M & Durand Jo. 2018. Chemnanomat. 46-51. DOI : 10.1002/cnma.201700264(IF : 2.937)

4- Can Heterocyclic γ‐Peptides Provide Polyfunctional Platforms for Synthetic Glycocluster Construction ? M. Simon, L.M.A. Ali, K. El Cheikh, J. Aguesseau, M. Gary‐Bobo, M. Garcia, A. Morère, L. T. Maillard, Chem. Eur. J. 2018, 24, 11426 – 11432.

5- Triphenylphosphonium-substituted phthalocyanine : Design, synthetic strategy, photoproperties and photodynamic activity. M. Tarhouni, D. Durand, E. Önal, D. Aggad, Ü. İşci, G. Ekineker, F. Brégier, B. Jamoussi, V. Sol, M. Gary-Bobo, F. Dumoulin, Journal Of Porphyrins And Phthalocyanines Vol. 22, No. 07, pp. 552-561, 2018

6- Multifunctional manganese-doped Prussian blue nanoparticles for two-photon photothermal therapy and magnetic resonance imaging. L.M.A. Ali, E. Mathlouthi, M. Kajdan, M. Daurat, J. Long, S. Boulenouar, M. Cardoso, C. Goze-Bac, N. Amdouni,Y. Guari, J. Larionova, M. Gary-Bobo. Photodiagnosis And Photodynamic Therapy. 2018

7- Photodynamic Therapy and Gene Delivery in Zebrafish. C. Mauriello Jimenez, D. Aggad, J.G. Croissant, K. Tresfield, D. Laurencin, D. Berthomieu, N. Cubedo, M. Rossel, S. Alsaiari, D. H. Anjum, R. Sougrat, M. A. Roldan-Gutierrez, S. Richeter, E. Oliviero, L. Raehm, C. Charnay, X. Cattoën, S. Clément, M. Wong Chi Man, M. Maynadier, V. Chaleix, V. Sol, M. Garcia, M. Gary-Bobo, N. M. Khashab, N. Bettache, J.-O. Durand. Adv. Funct. Mater. DOI : 10.1002/adfm.201800235. 2018

8- Two‐Photon Fluorescence Imaging and Therapy of Cancer Cells with Anisotropic Gold‐Nanoparticle‐Supported Porous Silicon Nanostructures. A. Chaix, K. Rajoua, V. Stojanovic, K. El Cheikh, E. Bouffard, A. Brocéro, M. Garcia, M. Maynadier, A. Morère, M. Gary‐Bobo, F. Favier, J.O. Durand, F. Cunin, Chemnanomat. 2018

9- Efficient therapy for refractory Pompe disease by mannose 6-phosphateanalogue grafting on acid αglucosidase. I. Basile, A. Da Silva, K. El Cheikh, A. Godefroy, M. Daurat, A. Harmois, M. Perez, C. Caillaud, H.-V. Charbonné, B. Pau, M. Gary-Bobo, A. Morère, Marcel Garcia, M. Maynadier. Jcr 269(2018)15-23. 2018

10- Indoloazepinone-Constrained Oligome rs as Cell-Penetrating and Blood–Brain-Barrier-Permeating Compounds. O. Van der Poorten, B. Legrand, L. Vezenkov, J. Garcia-Pindado, N. Bettache, A. Knuhtsen, D. Sejer Pedersen, M. Sanchez-Navarro, J. Martinez, M. Teixidj, M. Garcia, D. Tourw, M. Amblard, S. Ballet. Chembiochem, DOI:10.1002/cbic.201700678,2018

11- Mangifera indica Bark Essential Oil : Chemical Composition and Biological Activities in Comparison with Aqueous and Ethanol Extracts. Kemegne G.A., Nyegue M.A., Kamdem S.L.S., Etoa F.X., Menut C. Natural Product Communications. 2018

12- Prostatitis, other genitourinary infections and prostate cancer risk : Influence of non-steroidal anti-inflammatory drugs ? Results from the EPICAP study. Doat S., Marous M., Rebillard X., Tretarre B., Lamy P.J., Soares P., Delbos O., Thuret R. Segui B., Cenee S., Menegaux F.. International Journal Of Cancer, DOI : 10.1002/ijc.31565, 2018

13- Identifying patients with metastatic castration-resistant prostate cancers (mCRPC) in the SNDS database : Camerra Study. Thurin N., Blin P., Rouyer M., Jove J., Gross-Goupil M., Haaser T., Rebillard X., Soulie M., Capone C., Droz-Perroteau C., Moore N.. Pharmacoepidemiology And Drug Safety. 2018

14- Night work and prostate cancer risk : results from the EPICAP Study. Wendeu-Foyet M.G., Bayon V., Cenee S., Tretarre B., Rebillard X., Cancel-Tassin G., Cussenot O., Lamy P.J., Faraut B., Ben Khedher S., Leger D., Menegaux F.. Occupational And Environmental Medicine. DOI : 10.1136/oemed-2018-105009. 2018

15- Impact of prostate cancer diagnosis and type of treatment on the health-related quality of life and urological dysfunction at 3 years : A case-control study. Menegaux F., Rebillard X., Tretarre B., Bouvet S., Castelli C., Fiteni F.. Journal Of Clinical Oncology. DOI : 10.1200/JCO.2018.36.15_suppl.e17084, 2018

16- Impact of transient androgen deprivation therapy (adt) with leuprorelin lp 11.25 mg on the histological progression of indolent prostate cancer (pc)-results of a phase iii trial versus active surveillance (as) impact of transient androgen deprivation therapy (adt) with leuprorelin lp 11.25 mg on the histological progression of indolent prostate cancer (pc)-results of a phase iii trial versus active surveillance (as). Cussenot O., Penna R.R., Comperat E., Azzouzi A.R., Costa P., Larre S., Ruffion A., Fasla L., Delavierre D., Rebillard X., Pfister C., Fendler J.P., Vesga J.V., Staerman F..Journal Of Urology. APR 2018

17- The impact of prostate cancer diagnosis on the quality of life at 3 years : A case control study. Menegaux F., Rebillard X., Bouvet S., Castelli C., Houede N..Journal Of Clinical Oncology. DOI : 10.1200/JCO.2018.36.6_suppl.67. 2018

Publis 2017

1- Synthesis of mesoporous silica nanoparticles and nanorods : Application to doxorubicin delivery. Saher Rahmani, Jean-Olivier Durand, Clarence Charnay, Laure Lichon, Mokhtar Ferid, Marcel Garcia, Magali Gary-Bobo. Solid State Sciences, 2017, vol.68:25-31 (I.F. : 2.041)

2- Imidazopyridine-fused [1,3]-diazepinones part 2 : Structure-activity relationships and antiproliferative activity against melanoma cells. Virginie Bellet, Laure Lichon, Dominique P. Arama, Audrey Gallud, Vincent Lisowski, Ludovic T. Maillard, Marcel Garcia, Jean Martinez, Nicolas Masurier. Eur. J. Med.Chem 125. 2017. 1225e1234 (IF : 3.9)

3- Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications. W. Liu, A. Chaix, M. Gary-Bobo, B. Angeletti, A. Masion, A. Da Silva, M. Daurat, L. Lichon, M. Garcia, A. Morere, K. El Cheikh, JO. Durand, F. Cunin, M. Auffan, nanomaterials, 2017, 7(10)288, DOI : 10.3390/nano7100288.

4- Probing for the presence of glucosinolates in three Drypetes spp. (Drypetes euryodes (Hiern) Hutch., Drypetes gossweileri S. Moore, Drypetes laciniata Hutch.) and two Rinorea spp. (Rinorea subintegrifolia O. Ktze and Rinorea woermanniana (Buttner) Engl.) from Gabon. S.Montaut, GR. De Nicola, H.Agnaniet, Y. Issembe, P. Rollin, C. Menut .natural product research, 2017, 31(3)308-313 ; DOI : 10.1080/14786419.2016.1236099.

5- Rates of total and free PSA prescriptions in France (2012-2014). P. Tuppin, C. Leboucher, G. Peyre-Lanquar, PJ. Lamy, P. Gabach, X. Rebillard. Presse medicale, 2017, 46(10) E237- E247. DOI : 10.1016/j.lpm.2017.04.015

6- Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk : results from the EPICAP study. S. Doat, S. Cenee, B. Tretarre, X. Rebillard, PJ. Lamy, JP. Bringer, F. Iborra, T. Murez, M. Sanchez, F. Menegaux. Cancer medicine, 2017, 6(10)2461-2470. DOI : 10.1002/cam4.1186.

7- Chemotherapy in hormone-sensitive metastatic prostate cancer : Evidences and uncertainties from the literature. G. Gravis, F. Audenet, J. Irani, MO. Timsit, P. Barthelemy, P. Beuzeboc, A. Flechon, C. Linassier, S. Oudard, X. Rebillard, P. Richaud, M. Roupret, AT.Vuillemin, S. Vincendeau, L. Albiges, F. Rozet. Cancer treatment reviews, 2017, 55 : 211-217. DOI : 10.1016/j.ctrv.2016.09.008.

8- Robot assisted radical prostatectomy : What are the evidences at the time of a specific funding ? JA. Long, G. Poinas, G. Fiard, M. Lepretre, C. Delaitre-Bonnin, X. Rebillard, JL. Descotes.Progres en urologie, 2017, 27(3)146-157. DOI : 10.1016/j.purol.2016.12.010

9- Radium 223 dichloride for prostate cancer treatment. E.Deshayes, M. Roumiguie, C. Thibault, P. Beuzeboc, F. Cachin, C. Hennequin, D. Huglo, F. Rozet, D. Kassab-Chahmi, X. Rebillard. drug design development and therapy, 2017, 11 : 2643-2651. DOI : 10.2147/DDDT.S122417

10- Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer. R.Boissier, C. Udrescu, X. Rebillard, JE. Terrier, A. Faix, O. Chapet, D. Azria, M. Devonec, P. Paparel, A. Ruffion. urology, 2017, (99) 265-269. DOI : 10.1016/j.urology.2016.09.045

11- Porphyrin or phthalocyanine- bridged silsesquioxane theranostic nanoparticles for two-photon imaging, photodynamic therapy or photoacoustic imaging. Mauriello Jimenez C, Henry M, Aggad D, Raehm L, Cattoën X, Wong Chi Man M, Charnay C, Alpugan S, Ahsen V, Kutlu Tarakci D, Maillard P, Maynadier M, Garcia M, Dumoulin F, Gary-Bobo M, Coll Jl, Josserand V & Durand Jo. 2017. Nanoscale.16622-16626. DOI : 10.1039/c7nr04677d (IF : 7.367)

12- Ribbon-like Foldamers for Cellular Uptake and Drug Delivery. Vezenkov Ll, Martin V, Bettache N, Simon M, Messerschmitt A, Legrand B, Bantignies Jl, Subra G, Maynadier M, Bellet V, Garcia M, Martinez J, Amblard M. 2017. ChemBioChem ; 18(21):2110-2114.

13- Degradable gold core mesoporous organosilica shell nanoparticles for two-photon imaging and gemcitabine monophosphate delivery. Rahmani S, Chaix A, Aggad D, Hoang P, Moosa B, Garcia M, Gary-Bobo M, Charnay C, Almalik A, Durand Jo, Khashab Nm 2017. Molecular Systems Design & Engineering ; 2(4)380-383. (IF : pending)

14- Biocompatible Periodic Mesoporous Ionosilica Nanoparticles with Ammonium Walls : Application to Drug Delivery. Bouchal R, Daurat M, Gary-Bobo M, Da Silva A, Lesaffre L, Aggad D, Godefroy A, Dieudonné P, Charnay C, Durand Jo, Hesemann P. ACS Appl Mater Interfaces. 2017, doi : 10.1021/acsami.7b07264. (IF : 7.504)

15- Porphyrins Conjugated with Peripheral Thiolato Gold(I) Complexes for Enhanced Photodynamic Therapy. Longevial Jf, El Cheikh K, Aggad D, Lebrun A, Van Der Lee A, Tielens F, Clément S, Morère A, Garcia M, Gary-Bobo M, Richeter S. Chem Eur J. 2017, 23(56)14017-14026. (IF : 5.317)

16- Biological Fate of Fe3O4 Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry. Rascol E, Daurat M, Da Silva A, Maynadier M, Dorandeu C, Charnay C, Garcia M, Lai-Kee-Him J, Bron P, Auffan M, Liu W, Angeletti B, Devoisselle JM, Guari Y, Gary-Bobo M, Chopineau J. Nanomaterials, 2017, 7(7)162 , DOI : 10.3390/nano7070162 (IF : 3.553)

Publis 2016

1- Influence of geography, seasons and pedology on chemical composition and anti-inflammatory activities of essential oils from Lippia multiflora Mold leaves. Lêniféré C. Soro, S. Munier, Y. Pelissier, L. Grosmaire, R. Yada, D. Kitts, A. L. Ocho-Anin Atchibri, C. Guzman, F., C. Menut, J. C. Robinson, P. Poucheret. Journal of Ethnopharmacology. 194 (2016) 587–594. (IF:3.055)

2- Structure–Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties : The Unique Role of the AMPA-Based Vector L. Vezenkov, Clement A. Sanchez, V. Bellet, V. Martin, M. Maynadier, N. Bettache, V. Lisowski, J. Martinez, M. Garcia, M. Amblard, J.-F. Hernandez. 2016 ChemMedChem11(3):302-308.DOI : 10.1002/cmdc.201500457 (IF : 2.98)

3- Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer : Results from a population aged less than 65 years old Bessaoud F ,Orsini M , Iborra F , Rebillard X , Faix A ,Soulier M , Daures Jp , Tretarre B. 2016 Bulletin Du Cancer 829-840 DOI : 10.1016/j.bulcan.2016.09.011 (IF :0.706)

4- The level of evidence for the use of biomarkers in the early detection of prostate cancer Lamy Pj, Gauchez As, Salomon L , Haugh M , Ceraline J, Fulla Y, Georges A ,Larre S , Loric S, Luporsi E ,Martin, Pm ,Mazerolles C ,Molinie V, Mongiat-Artus P , Piffret J, Thuillier F , Perrin P, Rebillard X. 2016 Annales De Biologie Clinique 227-232 DOI : 10.1684/abc.2016.1128

5- Nanodiamond–PMO for two-photon PDT and drug delivery. C. Mauriello Jimenez, N. Z. Knezevic, Y.Gala`N Rubio, S. Szunerits, R. Boukherroub, F. Teodorescu, J. G. Croissant, O. Hocine, M. Seric, L. Raehm, V. Stojanovic, D. Aggad, M. Maynadier, M. Garcia, M. Gary-Bobo, J.-O. Durand. J. Mater. Chem. B. 2016. 4, 5803DOI : 10.1039/c6tb01915c

6- Optimization of antifungal activity of Aeollanthus heliotropioides oliv essential oil and Time Kill Kinetic Assay. M.N.L.Ngo Mback, H.Agnaniet, F.Nguimatsia, P.-M.Jazet Dongmo, J.-B. Hzounda Fokou, I.Bakarnga-Via, F.Fekam Boyom, C.Menut. J.Myc.Med ,2016, 26, 233—243

7- Biosynthesis of 2-acetyl-1-pyrroline in rice calli cultures : Demonstration of 1-pyrroline as a limiting substrate J. Poonlaphdecha, P. Gantet, I. Maraval, F.-X. Sauvage, C. Menut, A. Morère, R. Boulanger, M. Wüst, Z. Gunata. Food Chemistry, 197. 2016. 965-971 (IF : 4.052)

8- Convenient Synthesis of the Protein Thermal-Stabilizer Mannosylglycerate K. El Cheikh, E. Bouffard, N. Hamon, A. Morère. Chemistry Select, 2016, 1(10), 2471-2473.

9- Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease. El Cheikh K, Basile I, Da Silva A, Bernon C, Cérutti P, Salgues F, Perez M, Maynadier M, Gary-Bobo M, Caillaud C, Cérutti M, Garcia M, Morère A. Angew Chem Int Ed Engl 2016,DOI:10.1002/anie.201607824R2(IF : 11.3)

10- Potential of Porous Silicon Nanoparticles (pSiNPs) as an Emerging Platform for Cancer Theranostic. Stojanovic V, Cunin F, Durand Jo, Garcia M And Gary-Bobo M. J Mater Chem B. 2016, TB-REV-07-2016-001829.(IF : 4.872)

11- Core–shell nanodiamond–periodic mesoporous organosilica nanoparticles for two-photon imaging, photodynamic therapy and synergistic pH-responsive drug delivery Mauriello Jimenez C, Knezevic Nz, Galàn Rubio Y, Szunerits S, Boukherroub R, Teodorescu F, Croissant Jg, Hocine O, Seric M, Raehm L, Stojanovic V, Aggad D, Maynadier M, Garcia M, Gary-Bobo M And Durand Jo. J Mater Chem B. 2016, DOI : 10.1039/c6tb01915c (IF : 4.872)

12- Fluorescent Periodic Mesoporous Organosilica Nanoparticles Dual-Functionalized via Click Chemistry for Two-Photon Photodynamic Therapy in Cells. Croissant J, Picard S, Aggad D, Klausen M, Mauriello Jimenez C, Maynadier M, Mongin O, Clermont G, Genin E, Cattoën X, Wong Chi Man M, Raehm L, Garcia M, Gary-Bobo M, Blanchard-Desce M And Durand Jo. J Mater Chem B. 2016, 4, 5567.(IF : 4.872)

13- Synthesis, decoration, and cellular effects of magnetic mesoporous silica nanoparticles Nyalosaso Jl, Rascol E, Pisani C, Dorandeu C, Dumail X, Maynadier M, Gary-Bobo M, Lai Kee Him J, Bron P, Garcia M, Devoisselle Jm, Prat O, Guari Y, Charnay C And Chopineau J. RSC Adv 2016, DOI : 10.1039/c6ra09017f (IF : 3.84)

14- Bis-clickable mesoporous silica nanoparticles : straightforward preparation of light-actuated nanomachines for controlled drug delivery with active targeting.Noureddine A, Gary-Bobo M, Lichon L, Garcia M, Zink Ji, Wong Chi Man M, Cattoën X. Chem Eur J. 2016, DOI:10.1002/chem.201600870. (IF : 5.731)

15- Mesoporous silicon nanoparticles for targeted two-photon theranostic of prostate cancer. Chaix A, El Cheikh K, Bouffard E, Maynadier M, Aggad D, Stojanovic V, Knezevic N, Garcia M, Maillard P, Morère A, Gary-Bobo M, Raehm L, Richeter S, Cunin F. J Mater Chem B. 2016, DOI : 10.1039/c6tb00690f. (IF : 4.872)

16- 20 nm sized mesoporous silica nanoparticles with porphyrin photosensitizers for in-vitro photodynamic therapy. Mauriello Jimenez C, Galàn Rubio Y, Saunier V, Warther D, Stojanovic V, Raehm L, Frochot C, Arnoux P, Garcia M, Morère A, Bettache N, Maynadier M, Maillard P, Gary-Bobo M And Durand Jo. JSST 79(3), 447–456 2016 DOI:10.1007/s10971-016-3991-6 (IF : 1.532)

17- Antidiabetic potential of two medicinal plants used in Gabonese folk medicine Agnaniet H, Mbot Ej, Keita O, Fehrentz Ja, Ankli A, Gallud A, Garcia M, Gary-Bobo M, Lebibi J, Cresteil T, Menut C. BMC Complement Altern Med.2016, 16, 71. (IF : 2.02)

18- Ruthenium(II) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy. Knezevic Nz, Stojanovic V, Chaix A, Bouffard E, El Cheikh K, Morère A, Maynadier M, Lemercier G, Garcia M, Gary-Bobo M, Durand Jo And Cunin F. J Mater Chem B 2016, 4, 1337-42. (IF : 4.872)

19- Multifonctional gold-mesoporous silica nanocomposites for enhanced two-photon imaging and therapy of cancer cells. Croissant Jg, Qi C, Maynadier M, Cattoën X, Wong Chi Man M, Raehm L, Mongin O, Blanchard-Desce M, Garcia M, Gary-Bobo M And Durand Jo. Front Mol Biosci. 2016, doi:10.3389/fmolb.2016.00001.

20- Combination treatment with proteasome inhibitors and anti-estrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer. Maynadier M, Basile I, Gallud A, Gary-Bobo M, Garcia M Oncol Rep.1127-1134 2016(IF : 2.1)

Publis 2015

1- Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles. Gallud A, Warther D, Maynadier M., Sefta M, Poyer F, Thomas C, Rouxel C, Mongin O, Blanchard-Desce M, Morère A, Raehm L, Maillard P, Durand JO, Garcia M, Gary-Bobo M. RSC Adv. 2015 (IF : 3.84)

2- Multivalent DNA recognition by self-assembled clusters : deciphering structural effects by fragments screening and evaluation as siRNA vectors. Bartolami E, Bessin Y, Bettache N, Gary-Bobo M, Garcia M, Dumy P, Ulrich S. Org Biomol Chem, 13(36):9427-9438. 2015(IF : 3.562)

3- Why anticancer nanomedicine needs sugars ? Bouffard E, El Cheikh K,Gallud A, Da Silva A, Maynadier M, Basile I, Gary-Bobo M, Morere A, Garcia M. Curr Med Chem. 2015 (IF : 3.853)

4- pH-operated Hybrid Silica Nanoparticles with Multiple H-bond Stoppers for Colon Cancer Therapy.. Théron C, Gallud A, Giret S, Maynadier M, Grégoire D, Puche P, Jacquet E, Pop G, Sgarbura O, Bellet V, Hibner U, Zink Ji, Garcia M, Wong Chi Man M, Carcel C And Gary-Bobo M. RSC Advances 2015(IF : 3.84)

5- Disulfide-gated mesoporous silica nanoparticles designed for two-photon-triggered drug release and imaging. Croissant Jg, Qi C, Mongin O, Hugues V, Blanchard-Desce M, Raehm L, Cattoën X, Wong Chi Man M, Maynadier M, Gary-Bobo M, Garcia M, Zink Ji And Durand Jo. J Mater Chem B. 2015 (IF : 4.73)

6- Synthesis of disulfide-based biodegradable bridged silsesquioxane nanoparticles for two photon imaging and therapy of cancer cells. Croissant Jg, Mauriello-Jimenez C, Maynadier M, Cattoën X, Wong Chi Man M, Raehm L, Mongin O, Blanchard-Desce M, Garcia M, Gary-Bobo M, Maillard P And Durand Jo. Chem. Comm. 2015(IF : 6.83)

7- Prostate cancer : net survival and cause-specific survival rates after multiple imputation. Morisot A, Bessaoud F, Landais P, Rébillard X, Trétarre B, Daurès Jp. BMC Med Res Methodol. 2015 ;15(1):54. doi : 10.1186/s12874-015-0048-4.

8- Abiraterone acetate in patients with metastatic castration-resistant prostate cancer : long term outcome of the Temporary Authorization for Use programme in France. Houédé N, Beuzeboc P, Gourgou S, Tosi D, Moise L, Gravis G, Delva R, Fléchon A, Latorzeff I, Ferrero Jm, Oudard S, Tartas S, Laguerre B, Topart D, Roubaud G, Agherbi H, Rebillard X, Azria D. BMC Cancer. 2015 ;15:222. doi : 10.1186/s12885-015-1257-2.

9- Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer : a cross-sectional survey. Ariane MM, Ploussard G, Rebillard X, Malavaud B, Rischmann P, Hennequin C, Mongiat-Artus P. World J Urol. 2015. 33(11):1741-7. doi : 10.1007/s00345-015-1543-2.

10- Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing : New Insights from the European Randomized Study of Screening for Prostate Cancer. Buzzoni C, Auvinen A, Roobol Mj, Carlsson S, Moss Sm, Puliti D, De Koning Hj, Bangma Ch, Denis Lj, Kwiatkowski M, Lujan M, Nelen V, Paez A, Randazzo M, Rebillard X, Tammela Tl, Villers A, Hugosson J, Schröder Fh, Zappa M. Eur Urol. 2015. doi : 10.1016/j.eururo.2015.02.042.

11- Electrophysiological and behavioral characterization of bioactive compounds of the Thymus vulgaris, Cymbopogon winterianus, Cuminum cyminum and Cinnamomum zeylanicum essential oils against Anopheles gambiae and prospects for their use as bednet treatments. Deletre E, Chandre F, Williams L, Duménil C, Menut C, Martin T. Parasit Vectors. 2015 ;8(1):316. doi : 10.1186/s13071-015-0934-y.

12- Naturally occurring bioactive compounds from four repellent essential oils against Bemisia tabaci whiteflies. Deletre E, Chandre F, Barkman B, Menut C, Martin T. Pest Manag Sci. 2015. doi : 10.1002/ps.3987.

13- Chemical characterization of floral scents in the six endemic baobab species (Adansoniasp.)ofMadagascar.O.Razanamaro,E.Rasoamanana,B.Rakouth,J.Ramarolanonana,Randriamalala, E. Rabakonadrianina, A. Clement-Vidal, J-M. Leong Pock Tsy, C. Menut, P. Danthu.

14- Chemical Composition of Leaf Essential Oils of Lippia multiflora Mold. Grown in Savannah and Forest Area in the Ivory CoastLENIFERE C. Soro, S. Munier, Anin Louise Ocho-Anin Atchibri, L. Grosmaire, C. Menut, K. Anglade Malan, Y.Pelissier.

15- Controlled Multiple Functionalization of Mesoporous Silica Nanoparticles : Homogeneous Implementation of pairs of Functionalities Communicating through Energy or Proton Transfers. Noureddine A, Lichon L, Maynadier M, Garcia M, Gary-Bobo M, Zink Ji, Wong Chi Man M. Nanoscale 2015 (IF : 7.394)

16- Investigation of cyano-bridged coordination nanoparticles Gd3+/[Fe(CN)6]3-/d-mannitol as T1-weighted MRI contrast agents. Perrier M, Gallud A, Ayadi A, Kennouche S, Porredon C, Gary-Bobo M, Larionova J, Goze-Bac C, Zanca M, Garcia M, Basile I, Long J, De Lapuente J, Borras M, Guari Y. Nanoscale. 2015 (IF : 7.394)

17- Influence of the Synthetic Method on the Properties of Mesoporous Silica Nanoparticles Designed for Two-Photon Excitation.Croissant J, Mongin O, Hugues V, Blanchard-Desce M, Cattoën X, Wong Chi Man M, Charnay C, Maynadier M, Garcia M, Gary-Bobo M, Raehm L, Durand Jo. J Mater Chem B. 2015 (IF : 4.73)

18- Enhanced Two-Photon Fluorescence Imaging and Therapy of Cancer Cells via Gold@Bridged Silsesquioxane Nanoparticles. Croissant J, Maynadier M, Mongin O, Hugues V, Blanchard-Desce M, Chaix A, Cattoën X, Wong Chi Man M, Gallud A, Gary-Bobo M, Garcia M, Raehm L, Durand Jo. Small, 2015 11(3):295-9doi : 10.1002/smll.201401759.(IF : 7.82)

19- Porphyrin-Functionalized Mesoporous Organosilica Nanoparticles for Two-Photon Imaging of Cancer Cells and Drug Delivery. Auriello-Jimenez C, Croissant J, Maynadier M, Cattoën X, Wong Chi Man M, Vergnaud J, Chaleix V, Sol V, Garcia M, Gary-Bobo M, Raehm L, Durand Jo. J Mater Chem B, 2015 DOI:10.1039/c5tb00315f.(IF : 4.73)

20- Mannose-6-phosphate receptor as a new target for theranostic of prostate cancer. Vaillant O, El Cheikh K, Warther D, Brevet D, Maynadier M, Bouffard E, Salgues F, Jeanjean A, Puche P, Mazerolles M, Maillard P, Mongin O, Blanchard-Desce M, Raehm L, Rébillard X, Durand Jo, Gary-Bobo M, Morère A And Garcia M. Angew Chem Int Ed Engl. 2015. 54(20):5952-6DOI : 10.1002/anie.201500286. (IF : 11.3)

Publis 2014

1- Mixed Periodic Mesoporous Organosilica Nanoparticles and Core-Shell Systems, Application to in Vitro Two-Photon Imaging, Therapy and Drug Delivery . Croissant J, Salles D, Maynadier M, Mongin O, Hugues V, Blanchard-Desce M, Cattoën X, Wong Chi Man M, Gallud A, Garcia M, Gary-Bobo M, Raehm L, Durand Jo.Chem Mater 2014, 26(24), 7214-7220.(IF : 8.35)

2- Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy : results from a national multicentre study. Ploussard G, Staerman F, Pierrevelcin J, Larue S, Villers A, Ouzzane A, Bastide C, Gaschignard N, Buge F, Pfister C, Bonniol R, Rebillard X, Fadli S, Mottet N, Saint F, Saad R, Beauval Jb, Roupret M, Audenet F, Peyromaure M, Delongchamps Nb, Vincendeau S, Fardoun T, Rigaud J, Soulie M, Salomon L ; Committee Of Cancerology (Ccafu) Of The Association Of French Urology (Afu). World J Urol. 2014 ;32(5):1331-8. doi : 10.1007/s00345-013-1214-0. (IF : 3.423)

3- Screening and prostate cancer mortality : results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Schröder Fh, Hugosson J, Roobol Mj, Tammela Tl, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis Lj, Recker F, Paez A, Bangma Ch, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman Uh, Kujala P, Taari K, Aus G, Huber A, Van Der Kwast Th, Van Schaik Rh, De Koning Hj, Moss Sm, Auvinen A ; For The Erspc Investigators. Lancet. 2014. pii : S0140-6736(14)60525-0. doi : 10.1016/S0140-6736(14)60525-0. (IF : 39.207)

4- Prosbiotate : A multicentric, prospective analysis of infectious complications after prostate biopsy. Bruyère F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet Jd, Bernard L, Bugel H, Conquy S, Escaravage L, Sotto A, Boiteux Jp, Pogu B, Rebillard X, Mongiat-Artus P, Coloby P. J Urol. 2014. pii : S0022-5347(14)04035-X. doi : 10.1016/j.juro.2014.07.086 (IF : 3.753)

5- Two-Photon Excitation of Porphyrin-Functionalized Porous Silicon Nanoparticles for Photodynamic Therapy. Secret E, Maynadier M, Gallud A, Chaix A, Bouffard E, Gary-Bobo M, Marcotte N, Mongin O, El Cheikh K, Hugues V, Auffan M, Frochot C, Morère A, Maillard P, Blanchard-Desce M, Sailor Mj, Garcia M, Durand Jo, Cunin F. Adv Mater. 2014, 3 ;26(45):7643-8. (IF : 15.4)

6- Biodegradable Ethylene-Bis(Propyl)Disulfide-Based Periodic Mesoporous Organosilica Nanorods and Nanospheres for Efficient In-Vitro Drug Delivery. Croissant J, Cattoën X, Man Mw, Gallud A, Raehm L, Trens P, Maynadier M, Durand Jo. Adv Mater. 2014. 17 ;26(35):6174-80. doi : 10.1002/adma.201401931. (IF : 15.4)

7- Small sized mesoporous silica nanoparticlesfunctionalized with mannose for retinoblastomacell imaging. Warther D, Mauriello Jimenez C, Raehm L, Gérardin C, Durand Jo, Morère A, El Cheikh K, Gallud A, Gary-Bobo M, Maynadier M And Garcia M. RSC Adv. 2014, 4, 37171. (IF : 3.7)

8- Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding stoppers as an autonomous drug delivery system. C. THERON, A. GALLUD, C. CARCEL, M. GARY-BOBO, M. MAYNADIER, M. GARCIA, J. LU, F. TAMANOI, J.I. ZINK, M. WON CHI MAN. Chemistry, (2014) 20(30):9372-80. (IF : 5.925)

9- Comparative chemical study and cytotoxic activity of Uvariodendron angustifolium essential oils from Benin. J.P. Noudogbessi, M. Gary-Bobo, A. Adomou, E. Adjalian, G.A. Alitonou, F. Avlessi, M. Garcia, D.C. Sohounhloue, C. Menut. Nat Prod Commun. (2014) ,9(2):261-4. (IF : 0.96)

10- Composition and cytotoxic activity of essential oils from Xylopia aethiopica (Dunal) A. Rich, Xylopia parviflora (A. Rich) Benth.) and Monodora myristica (Gaertn) growing in Chad and Cameroon. I. Bakarnga-Via, J.B. Hzouda, P.V. Fokou, L.R. Tchokouaha, M. Gary-Bobo, A. Gallud, M. Garcia, L. Walbadet, Y. Secka, P.M. Dongmo, F.F. Boyom, C. Menut. BMC Complement Altern Med., (2014), 14(1):125. (IF : 1.88)

11- Epidemiological study of prostate cancer (EPICAP) : a population-based case-control study in France. F. Menegaux, A. Anger, H. Randrianasoslo, C. Mulot, P. Laurent-Puig, F. Iborra, J.P. Bringer, B. Leizour, R. Thuret, P.J. Lamy, X. Rebillard, B. Tretarre. BMC Cancer. (2014)19 ;14:106. (IF : 3.333)

12- Bark essential oil of Cedrelopsis grevei from Madagascar : investigation of steam-distillation conditions. Rakotobe M, Menut C, Andrianoelisoa Hs, Rahajanirina V, Tsy Jm, Rakotoarimanana V, Ramavovololona P, Danthu P. Chem Biodivers. 2014 ;11(2):323-31. doi : 10.1002/cbdv.201300227. (IF : 1.795)

13- Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer : long-term results of a phase 1 trial. D. Azria, O. Riou, X. Rebillard, S. Thezenas, R. Thuret, P. Fenoglietto, D. Pouessel, S. Culine. Int J Radiat Oncol Biol Phys. (2014),15 ;88(4):853-9. (IF : 4.764)

14- Imidazopyridine-fused [1,3]-diazepinones : synthesis and antiproliferative activity. A. Gallud, O. Vaillant, L.T. Maillard, D.P. Arama, J. Dubois, M. Maynadier, V. Lisowski, M. Garcia, J. Martinez, N. Masurier. Eur J Med Chem, (2014), 75:382-90. (IF : 3.499)

15- Two-Photon-Triggered Drug Release via Multifunctional Nanovalve. J. Croissant, A. Chaix, M. Wang, S. Clement, L. Raehm, J.O. Durand, M. Wong Chi Man, O. Mongin, M. Blanchard-Desce, M. Maynadier, A. Gallud, M. Gary-Bobo, M. Garcia, D.Y. Tam, J.I. Zink, J. Lu, F. Tamanoi. Small, (2014), 10(9):1752-5. (IF : 7.823)

Publis 2013

1- Two-Photon-Triggered Drug Delivery in Cancer Cells via Nanoimpellers. J. Croissant, M. Maynadier, A. Gallud, H. Peindy N’dongo, J.L Nyalosaso, G. Derrien, C. Charnay, J.O. Durand, L. Raehm, F. Serein-Spirau, N. Cheminet, T. Jarrosson, O. Mongin, M. Blanchard-Desce, M. Gary-Bobo, M. Garcia, J. Lu, F. Tamanoi, D. Tarn, T.M. Guardado-Alvarez, J.I. Zink. Angew Chem Int Ed Engl. (2013), 52(51):13813-7 (IF : 13.4)

2- Microarray gene expression profiling and analysis of bladder cancer supports the sub classification of the T1 tumours in T1a and T1b stages. F. Descotes, P.Dessen, P.P. Bringuier, M. Decaussin, P.M. Martin, M. Adams, A. Villers, E. Lechevallier, X. Rebillard, C Rodriguez-Lafrasse, M. Devonec, P. Paparel, P. Perrin, V. Lazar, A. Ruffion. BJU Int., (2014), 113(2):333-42 (IF : 3.046)

3- Repellent, irritant and toxic effects of 20 plant extracts on adults of the malaria vector Anopheles gambiae mosquito E. Deletre, T. Martin, P.Campagne, D. Bourguet, A. Cadin, C. Menut, R. Bonafos, F. Chandre. Plos One, (2013), 8(12):e82103 (IF : 3.534)

4- Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment M. Maynadier, R. Famoud, P.J. Lamy, M. Garcia, H. Rochefort. Int. J. Oncol., (2013), 43 : 1683-1690 (IF : 2.66)

5- Dipeptide mimic oligomer transporter mediates intracellular delivery of cathepsin D inhibitors : a potential target for cancer therapy. M. Maynadier, L. Vezenkov, M. Amblard, V. Martin, C. Gandreuil, O. Vaillant, M. Gary-Bobo, I. Basile, J.F. Hernandez, M. Garcia, J. Martinez. J. Control. Release, (2013), 171, 251-257(IF : 7.6)

6- Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN. Cancer Cell Int. 2013, 15 ;13(1):70. doi : 10.1186/1475-2867-13-70, (IF : 2.01).

7- Functionalized Nanoparticles for Drug Delivery, One- and Two-photon Photodynamic Therapy as a Promising Treatment of Retinoblastoma A. Gallud, A. Da Silva, M. Maynadier, I. Basile, S. Fontanel, C. Lemaire, P. Maillard, M. Blanchard-Desce, O. Mongin, A. Morere, J.O. Durand, L. Raehm, M. Garcia, M. Gary-Bobo. J Clin Exp Ophthalmol, (2013), 4:4 doi.10.4172/2155-9570.1000288 (IF : 1.625)

8- A Designed 5-FU Based-bridged Silsesquioxane as Autonomous Acid triggered Drug Delivery System. S. Giret, C. Theron, A. Gallud, M. Maynadier, M. Gary-Bobo, M. Garcia, M. Wong Chi Man, C. Carcel. Chem Eur J 16 ;19(38):12806-14DOI : 10.1002/chem.201301081 (2013) (IF:5.925)

9- Acaricidal activity of essential oils from five endemic conifers of New Caledonia on the cattle tick Rhipicephalus (Boophilus) microplus N. Lebouvier, T. Hue, E. Hnawia, L. Lesaffre, C. Menut, M. Nour. Parasitol Res, 112, 1379-84 (2013) (IF : 2.1)

10- Stability of Benzylic-Type Isothiocyanates in Hydrodistillation-Mimicking Conditions Gr. De Nicola, S. Montaut, P. Rollin, M. Nyegue, C. Menut, R. Iori, A. Tatibouet. J Agric Food Chem, 61, 137-42 (2013) (IF : 2.8)

11- Mannose-functionalized porous silica-coated magnetic nanoparticles for two-photon imaging or PDT of cancer cells M.Perrier, M. Gary-Bobo, L. Lartigue, D. Brevet, A. Morere, M. Garcia, P. Maillard, L. Raehm, Y. Guari, J. Larionova, Jo. Durand, O. Mongin, M. Blanchard-Desce. J Nanopart Res, 15 ; 1602-1609 (2013) (IF : 3.287)

12- Targeting multiplicity : the key factor for anti-cancer nanoparticles M. Gary-Bobo, O. Vaillant, M. Maynadier, I. Basile, A. Gallud, K. El Cheikh, E. Bouffard, A. Morere, X. Rebillard, P. Puche, P. Nirde, M. Garcia. Current Med Chem, 20, 1-10 (2013) (IF : 4.859)

13- Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy E. Secret, M. Maynadier, A. Gallud, M. Gary-Bobo, A. Chaix, E. Belamie, P. Maillard, Mj. Sailor, M. Garcia, J.O. Durand, F. Cunin. Chem Commun, 49, 4202-4 (2013)(IF : 6.169)


1. Berthou C, Bondu S, Deslandes E, El Cheikh K, Morère A, Bouffard E, Fabre MS,
Roue-Fourmantin N, Utilisation du mannosylglycérate et ses dérivés comme agent immunostimulant. French patent n°1455818.

2. Garcia M, Vaillant O., Rébillard X, Gary-Bobo M, Morère A, Mazerolles C, Nouvelle méthode de dépistage du cancer de la prostate. Brevet d’invention, N° BFF130690 (23 1 2014) demandeur CNRS

3. Cunin F., Durand J-O, Garcia M, Sailor M, Secret E, Maynadier M, Gary-Bobo M, Nanoparticules de silicium poreux fonctionnalisées et leur utilisation en thérapie photodynamique. Brevet d’invention, N° FR1252703 (2012), demandeur CNRS.

4. Morère, C. Menut, Z. Gunata, A. Agrebi, Nouvelle méthode de synthèse de la 2-acétyl-1-pyrroline et de son précurseur stable, marqué isotopiquement ou non. Brevet d’invention déposé le 24 juin 2009 Demande (2010), FR 2947267 ; PCT Int. Appl. (2010), WO 2010149744

5. J-L. Montero, I. Zgani, C. Menut, V. Gallois. Phosphonates useful as modulators of t-GAMMA-9-DELTA-2 activity. Extension USA, n° 10/498,313 (2009).

6. Garcia M., Morère A., Cérutti M., Gary-Bobo M., Nirdé P., Basile I., El Cheikh K.,. Neoglycoenzymes pour le traitement des maladies lysosomales. Brevet d’invention européen, N° EP 09305647, (2009), demandeur INSERM, PCT/EP2010/059507, WO 2011/000958.

7. Amblard M, Martinez J, Hernandez JF, Maynadier M, Garcia M, Oligomères de mimes contraints de dipeptides. Brevet d’invention, N° FR 0955427 (2009), demandeur CNRS, PCT/EP2010/061229, WO 2011/ 012729.

8. Blanchard-Desce M., Garcia M., Brevet D., Raehm L., Mongin O., Gary-Bobo M., Morère A., Durand J-O. Photosensibilisateurs biphotoniques, nanoparticules les comprenant. Brevet d’invention, N° EP 09 306 238.8 (2009), demandeur CNRS, PCT/EP2010/069035, WO2011/073054.

9. Durand J.O., Garcia M., Maillard P., Morère A., Smaihi M., Gary-Bobo M., Brevet D., Hocine O., Dérivés de métalloporphyrines, nanoparticules les comprenant. Brevet d’invention, N° 08/05034 (2008), demandeur CNRS, PCT/Fr 2009/001090, WO 2010/9409003.